QS Investors, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 241 filers reported holding NOVOCURE LTD in Q3 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2021$358,000
+67.3%
1,6120.0%0.00%
+100.0%
Q1 2021$214,000
-85.4%
1,612
-81.0%
0.00%
-88.9%
Q4 2020$1,464,000
+59.3%
8,462
+2.6%
0.02%
+50.0%
Q3 2020$919,000
-72.4%
8,250
-85.3%
0.01%
-73.9%
Q2 2020$3,331,000
-12.1%
56,160
-0.2%
0.05%
-23.3%
Q1 2020$3,790,000
-12.0%
56,270
+0.5%
0.06%
+39.5%
Q4 2019$4,305,000
+1.7%
56,010
-1.0%
0.04%
-6.5%
Q3 2019$4,233,000
+48.4%
56,600
+25.5%
0.05%
+48.4%
Q2 2019$2,852,000
+31.2%
45,1000.0%0.03%
+29.2%
Q1 2019$2,173,000
+3004.3%
45,100
+2047.6%
0.02%
+2300.0%
Q4 2018$70,0002,1000.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders